Tevogen Bio Holdings Inc (TVGN) has a current Price-to-Book (P/B) ratio of -4.32. Compared to its 3-year average P/B ratio of -10.85, the current P/B ratio is approximately -60.19% higher. Relative to its 5-year average P/B ratio of -11.67, the current P/B ratio is about -62.98% higher. Tevogen Bio Holdings Inc (TVGN) has a Forward Free Cash Flow (FCF) yield of approximately -18.25%. Compared to its 3-year average FCF yield of -7.07%, the current FCF yield is approximately 158.22% lower. Relative to its 5-year average FCF yield of -7.07%, the current FCF yield is about 158.22% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for TVGN competitors is 10.63, providing a benchmark for relative valuation. Tevogen Bio Holdings Inc Corp (TVGN.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of TVGN increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of TVGN in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is TVGN currently overvalued or undervalued?

What is Tevogen Bio Holdings Inc (TVGN) fair value?

TVGN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Tevogen Bio Holdings Inc (TVGN) is between to according to relative valuation method.

How does TVGN's valuation metrics compare to the industry average?

The average P/S ratio for TVGN's competitors is 10.63, providing a benchmark for relative valuation. Tevogen Bio Holdings Inc Corp (TVGN) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Tevogen Bio Holdings Inc (TVGN) as of Mar 03 2026?

As of Mar 03 2026, Tevogen Bio Holdings Inc (TVGN) has a P/B ratio of -4.32. This indicates that the market values TVGN at -4.32 times its book value.

What is the current FCF Yield for Tevogen Bio Holdings Inc (TVGN) as of Mar 03 2026?

As of Mar 03 2026, Tevogen Bio Holdings Inc (TVGN) has a FCF Yield of -18.25%. This means that for every dollar of Tevogen Bio Holdings Inc's market capitalization, the company generates -18.25 cents in free cash flow.

What is the current Forward P/E ratio for Tevogen Bio Holdings Inc (TVGN) as of Mar 03 2026?

As of Mar 03 2026, Tevogen Bio Holdings Inc (TVGN) has a Forward P/E ratio of -1.80. This means the market is willing to pay $-1.80 for every dollar of Tevogen Bio Holdings Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Tevogen Bio Holdings Inc (TVGN) as of Mar 03 2026?

As of Mar 03 2026, Tevogen Bio Holdings Inc (TVGN) has a Forward P/S ratio of 0.00. This means the market is valuing TVGN at $0.00 for every dollar of expected revenue over the next 12 months.

TVGN Valuation